Janus Henderson Investors US’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $33.3M | Buy |
649,399
+131,969
| +26% | +$6.76M | 0.03% | 523 |
|
|
2016
Q4 | $19.4M | Buy |
517,430
+18,393
| +4% | +$689K | 0.02% | 619 |
|
|
2016
Q3 | $33.8M | Buy |
499,037
+140,915
| +39% | +$9.55M | 0.03% | 507 |
|
|
2016
Q2 | $19.9M | Buy |
358,122
+322,622
| +909% | +$17.9M | 0.02% | 576 |
|
|
2016
Q1 | $2.23M | Buy |
35,500
+14,200
| +67% | +$891K | ﹤0.01% | 896 |
|
|
2015
Q4 | $2.01M | Sell |
21,300
-37,100
| -64% | -$3.49M | ﹤0.01% | 943 |
|
|
2015
Q3 | $4.69M | Sell |
58,400
-16,600
| -22% | -$1.33M | ﹤0.01% | 838 |
|
|
2015
Q2 | $8.99M | Buy |
75,000
+6,800
| +10% | +$815K | 0.01% | 714 |
|
|
2015
Q1 | $7.12M | Buy |
68,200
+55,800
| +450% | +$5.83M | 0.01% | 734 |
|
|
2014
Q4 | $1.2M | Buy |
+12,400
| New | +$1.2M | ﹤0.01% | 957 |
|